Nicotine and toxicant yield ratings of electronic cigarette brands in New Zealand

New Zealand Medical Journal

Volumn 128, Issue 1411, 2015, Pages 77-82

  Laugesen, Murray ^a  

^a Health New Zealand Ltd (a nicotine and tobacco research and policy consultancy)   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ACROLEIN; CIGARETTE SMOKE; DIETHYLENE GLYCOL; ETHYLENE GLYCOL; FORMALDEHYDE; GLYCEROL; NICOTINE; PROPYLENE GLYCOL; TOXIC SUBSTANCE; ELECTRONIC CIGARETTE;

ARTICLE; CHEMICAL COMPOSITION; ELECTRONIC CIGARETTE; NEW ZEALAND; VAPOR; CHEMISTRY; TOBACCO;

ELECTRONIC CIGARETTES; NEW ZEALAND; NICOTINE; TOBACCO;

EID: 84929672740     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bullen C, McRobbie H, Thornley S, et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomized cross-over trial. Tobacco Control 2010 April;19: 98-103. doi:10.1136/tc.2009.031567.
2. Lauterbach JH, Laugesen M. Comparison of toxicant levels in mainstream aerosols generated by Ruyan® electronic nicotine delivery systems (ENDS) and conventional cigarette products. Poster # 1861, Society of Toxicology, San Francisco. The Toxicologist CD, J of the Soc of Toxicology 2012 Mar; 126: http://www.healthnz.co.nz/News2012.htm.
3. Laugesen M. Safety report on the Ruyan e-Cigarette cartridge and inhaled aerosol. Christchurch New Zealand. 40 pages. http://www.healthnz.co.nz/RuyanCartridgeReport30-Oct 08.pdf accessed 16 March 2015.
4. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013;382:1629-37. http://dx.doi.org/10.1016/S0140-6736(13)61842-5. Published on-line 8 Sept 2013.
5. Caponnetto P, Campagna D, Cibella F, et al. Efficiency and Safety of an electronic cigarette (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study. Plus One 2013;June:8:e66317.
6. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. (Review).Cochrane Database of systematic reviews 2014.Issue 12. Art No. CD010216. doi:10.1002/146551858.CD010216. pub 2.
7. Counts ME, Morton MJ, Laffoon SW. et al. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine smoking test modes. Regulatory Toxicology and Pharmacology 2005;41:185-227, at Appendix C, re Marlboro KSF SP for the US market.
8. Grace RC, Kivell BM, Laugesen M. Estimating cross-price elasticity of nicotine e-cigarettes using a simulated demand procedure. Nicotine Tob Res. 2014 Dec 28. pii: ntu268. [Epub ahead of print].
9. Goniewicz M, Knysak J, Gawron M, et al. Levels of selected nicotine carcinogens and toxicants in vapour from electronic cigarettes. Tobacco Control On Line First, March 6, 2013, as 10.1136/tobaccocontrol,2012.050859.
10. Canadian Tobacco Reporting Regulations: 2000-07-19 Canada Gazette Part II, Vol. 134, No. 15 Part 3: Emissions from Designated Tobacco Products. Test method numbers refer to Health Canada methodologies which have been posted by Health Canada on the internet at site. http://www.hcsc. gc.ca/hc-ps/tobac-tabac/legislation/reg/indust/index-eng.php.
11. Arts JHE, Rennen MAJ, De Heer C. Inhaled formaldehyde: evaluation of sensory irritation in relation to carcinogenicity. Regul Toxicol Pharmacol 2006;44:144-160.
12. Etter J-F, Zather E, Svenson S. Analysis of refill liquids for electronic cigarettes. Addiction 2013;108:1671-9.
13. Laugesen M. Nicotine and Health.71 pages. New York: American Council on Science and Health. 2013 http://www.acsh.org.
14. Li J, Newcombe R, Walton D., The use of, and attitudes towards, electronic cigarettes and self-reported exposure to advertising and the product in general. Aust N Z J Public Health. 2014;38(6):524-8.